Teen Cured of Rare Disease in Gene-Editing First

Ty Sperle walked into a Montreal hospital room last year expecting nothing special. He walked out as the first person in the world cured by a revolutionary gene-editing technology called prime editing.

The Kelowna, B.C. resident had lived with chronic granulomatous disease since age five. The rare genetic condition left his immune system unable to fight off infections properly, meaning even a camping trip or a day outdoors could turn deadly.

"I was on a regimen of pills and all those are gone, so I don't have to take medication anymore, which is just amazing," Sperle says. Before the treatment, he swallowed antibiotics and antifungal medications every single day, knowing that even with those precautions, a serious infection could strike at any moment.

Traditional treatment would have required chemotherapy followed by a bone marrow transplant from a healthy donor. But Sperle didn't have a good match, leaving him in medical limbo until his doctor, pediatric immunologist Stuart Turvey, heard about the clinical trial.

The prime editing treatment worked like a biological spell-checker. Doctors extracted Sperle's own cells, corrected the genetic "spelling mistake" causing his disease, and returned the fixed cells to his body where they multiplied and took over.

Because the cells were his own, just repaired, his body accepted them without rejection. No donor needed. No immune system attack.

"When they put the transplant thing inside me, I was super stressed out, unimaginable stress," Sperle admits. But that stress dissolved into "insane shock" and indescribable happiness when doctors told him he was cured.

His mother, waiting outside the room, broke into "instant tears" when he shared the news. Now a second-year science student at UBC Okanagan, Sperle can finally do normal things like camping without calculating infection risks.

Why This Inspires

This isn't just one teen's miracle. It's proof that a new technology can actually cure genetic diseases that were once death sentences.

Turvey estimates that about one in three children admitted to BC Children's Hospital has a rare disease. Individually rare conditions are collectively common, affecting millions of families worldwide who've been told to just manage symptoms and hope.

The results appeared in the prestigious New England Journal of Medicine in December, giving other families facing genetic diseases something they haven't had before: real hope that a cure might be coming. Turvey calls Sperle's recovery a "dream come true" and a "miracle," but it's actually something better than magic. It's replicable science.

The challenge now isn't whether the technology works. It's making it routinely available through healthcare systems so other patients don't have to wait for experimental trials.

British Columbia's health minister Josie Osborne calls Sperle's successful treatment a milestone showing the power of public healthcare, research collaboration, and smart investment in science.

For Sperle, the biggest change is simple: he gets to live without fear, take zero daily medications, and plan a future he wasn't sure he'd have.